Rock ‘n’ Roll Marathon Series
The first physician to launch a successful career in the healthcare investment sector, Mitchell invests in healthcare companies as the founder of Consonance Capital in New York. Mitchell Blutt also formerly served on the board of directors for the Michael J. Fox Foundation, which welcomes members of the public to contribute toward finding a cure for Parkinson’s by joining Team Fox for athletic events such as the 2017 Rock ‘n’ Roll Marathon Series.
The Rock ‘n’ Roll Marathon Series began with the simple idea of a marathon with bands positioned along the course to cheer on participants. Celebrating its 20th year, the event has grown into a nationwide series of marathons consisting of a weekend of entertainment and runs to support participating charities. The world-class Health and Fitness Expo takes place alongside the marathon. The event concludes with a concert featuring big name musical performers.
Team Fox will participate in two upcoming marathons in the 2017 Rock n’ Roll Series: one in Brooklyn, New York, on October 14 and one in San Antonio, Texas, on December 2 through December 3. Runners who become a member of Team Fox will receive guaranteed entry into the race, running singlet for race day, and a personal fundraising page. Runners must commit to a specific fundraising goal based on race participation and those who meet their goal will receive a commemorative medal.
Addiction Speaker Series
Mitchell Blutt, MD, is CEO and founder of Consonance Capital , a healthcare investment firm based in New York City. Dr. Mitchell Blutt also serves as a clinical assistant professor at Weill Cornell Medical College and is a former member of the advisory board for CASA, The National Center on Addiction and Substance Abuse.
CASA, founded in 1992, strives to “connect science with policy and practice” in the field of addiction and substance abuse, with the ultimate goal of improving the lives of those afflicted both directly and indirectly by this destructive illness.
To date, CASA researchers have published more than 200 articles on substance abuse and addiction. In addition, the organization is dedicated to keeping the public informed on the importance of preventing substance use by children, and the misunderstood nature of addiction, which is often seen as a choice rather than an illness. CASA also highlights nationwide shortcomings such as the mere two cents of every dollar of federal spending received each year for addiction prevention and treatment.
The organization’s Addiction Speaker Series brings in experts whose talks on topics as diverse as “Digital Interventions to Reduce Problem Substance Use” and “Adolescent Substance Misuse Prevention” are available both live at CASA’s New York office, and as webinars. The series is free but the live events require registration.
Bridging the Gap
A pioneer in the healthcare investment business, Dr. Mitchell Blutt founded Consonance Capital in 2005 and leads the firm as chief executive officer. Mitchell Blutt began his medical career by earning his doctor of medicine from the University of Pennsylvania Perelman School of Medicine, which participates in community outreach through the Bridging the Gaps program.
Founded in 1991, the Bridging the Gaps (BTG) program draws students from a diverse array of disciplines attending the University of Pennsylvania, Philadelphia College of Osteopathic Medicine, Drexel University, Temple University, and Thomas Jefferson University. One of the main components of the program is the Community Health Internship Program (BTG CHIP).
Through the BTG CHIP Program, students engage in a paid summer internship through which they gain insight into the complex factors that impact the health of individuals in economically disadvantaged communities. Additionally, the program gives students a unique opportunity to collaborate across disciplines.
The BTG CHIP Program places students in some 100 nonprofit organizations in Pennsylvania and New Jersey. Students work in teams alongside site staff members and faculty to create projects that both meet the needs of community members and further students’ knowledge in their areas of academic interest. To learn more about the BTG CHIP program, visit http://www.med.upenn.edu/btg.
Over the course of more than a decade, Dr. Mitchell Blutt has divided his time between his responsibilities as the chief executive officer of Consonance Capital and as a clinical assistant professor of medicine at Weill Cornell Medical College. Outside of his professional endeavors, Dr. Mitchell Blutt leverages his experience in the health care field to serve on the board of directors of The Commonwealth Fund.
Since its inception nearly a century ago, The Commonwealth Fund has upheld the mission of improving the American health care system so that it can better support those most in need. In addition to providing medical grants to outside entities, the fund hosts a number of programs focused on specific health care topics.
One such initiative, known as the Health Care Delivery System Reform program, takes a closer look at the most vulnerable patient communities in the United States and the issues that they face related to health care delivery. Overall, there are two primary groups that fall under this category: those with serious conditions, which may include functional limitations that make daily life difficult, and those who with low incomes who likely do not have health insurance.
The Commonwealth Fund’s reform program aims to make quality care more accessible to both of these parties in a number of ways. The first of these focuses on improving and changing the policies that surround the current health care delivery system. Supporting these efforts, the program also researches any health care operations and models that can improve treatment for all. Chiefly, the Commonwealth Fund is dedicated to studying these two patient communities so that it may facilitate better care for both of them.